Oregon Health and Science University: Sclerosis trials

The registry lists 17 Sclerosis studies with Oregon Health and Science University as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 6Phase 2 7Phase 3 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Aerobic Exercise for Remyelination in Multiple SclerosisCompletedNCT04539002Not applicableResults posted
• Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding StudyCompletedNCT02760056Phase 1Results posted
• Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple SclerosisCompletedNCT02133664Phase 1/2Results posted
• Methylphenidate to Improve Balance and Walking in MSCompletedNCT01896700Phase 2/3Results posted
• Dalfampridine for Imbalance in Multiple SclerosisCompletedNCT01444300Phase 2Results posted
• American Ginseng Treatment for Multiple Sclerosis Related FatigueCompletedNCT00754832Phase 2Results posted
• Fish Oil for the Treatment of Depression in Patients With Multiple SclerosisCompletedNCT00122954Phase 1/2Results posted
• Low Fat Diet for Fatigue in MSStatus unknownNCT03322982Not applicable
• MitoQ for Fatigue in Multiple SclerosisTerminatedNCT03166800Phase 1/2
• Evaluation of a Web-Based Fall Prevention Program on People With Multiple SclerosisCompletedNCT02885233Not applicable
• Tecfidera and MRI for Brain Energy in MSTerminatedNCT02644083
• Rouxbe Pilot for MSCompletedNCT02424825Not applicable
• Pilot Study of Free From Falls Program in Multiple SclerosisCompletedNCT01829776Not applicable
• Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple SclerosisCompletedNCT01596881
• Low Fat Diet and Multiple SclerosisCompletedNCT00852722Phase 1
• A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple SclerosisCompletedNCT00676156Phase 1
• Trial of Memantine for Cognitive Impairment in Multiple SclerosisCompletedNCT00300716Phase 2/3